Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Microchip Technology announces dsPIC33CH512MP508 dual-core & dsPIC33CK64MP105 single-core Digital Signal Controllers (DSCs) March 13, 2019 CBI arrests telecom firm promoter Sunil Kakkad in Rs126 crore bank loan scam May 12, 2017 HDFC Bank vies for bond crown amid record sales July 18, 2017
Microchip Technology announces dsPIC33CH512MP508 dual-core & dsPIC33CK64MP105 single-core Digital Signal Controllers (DSCs) March 13, 2019